Allovate, LLC
Recent Peer-Reviewed Publication Confirms Patient Satisfaction with Multiple Allergy Immunotherapy Options
November 17, 2021 09:30 ET | Allovate, LLC
New York, Nov. 17, 2021 (GLOBE NEWSWIRE) -- A recent article in the peer-reviewed journal International Forum of Allergy and Rhinology reported the results of a survey offered to individuals with...
Allovate, LLC
Allovate Therapeutics Extends Free Allerdent® Program
July 23, 2020 15:37 ET | Allovate, LLC
New York, July 23, 2020 (GLOBE NEWSWIRE) -- Allovate Therapeutics, a New York-based biotechnology company, announced today that it has extended its free Allerdent® program. Allerdent® is a...
Allovate, LLC
Allovate Therapeutics Provides Free Allerdent® To Physicians
May 06, 2020 09:05 ET | Allovate, LLC
New York, May 06, 2020 (GLOBE NEWSWIRE) -- Allovate Therapeutics, a New York-based biotechnology company, announced today that it is making its allergy immunotherapy delivery platform available...
Allovate, LLC
Allovate Therapeutics Appoints Bob Pomrenke as CEO
April 02, 2019 14:04 ET | Allovate, LLC
New York, April 02, 2019 (GLOBE NEWSWIRE) -- Allovate Therapeutics (“Allovate®”), a New York-based biotechnology company focused on improving treatment for allergies, is pleased to announce the...
Allovate, LLC
Allovate Therapeutics Announces Grant of European Patent Covering Oral Mucosal Immunotherapy Platform
March 08, 2019 10:01 ET | Allovate, LLC
New York, March 08, 2019 (GLOBE NEWSWIRE) -- Allovate Therapeutics (“Allovate®”), a New York-based biotechnology company focused on improving treatment for allergies, is pleased to announce that the...
Allovate, LLC
Allovate Therapeutics Announces Issuance of Second Japanese Patent, Expanding Global Coverage of the Oral Mucosal Immunotherapy Platform
March 21, 2018 08:37 ET | Allovate, LLC
New York, March 21, 2018 (GLOBE NEWSWIRE) -- Allovate Therapeutics, a biopharmaceutical company focused on improving treatment options for allergies, announced today that the...
Allovate, LLC
New “Test and Treatment” Allergy Program Enables All Physicians To Provide Convenient And Effective Allergy Care
December 19, 2017 08:17 ET | Allovate, LLC
New York City, Dec. 19, 2017 (GLOBE NEWSWIRE) -- Pediatric Allergy Solutions (“PAS”) and Allovate Therapeutics (“Allovate®”) announce that they have signed an exclusive agreement to combine PAS’s...